Hyperoxaluria Clinical Trials in Lyon
2 recruitingLyon, France
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
Phase 1/2 Study of ABO-101 in Primary Hyperoxaluria Type 1 (redePHine)
Primary Hyperoxaluria Type 1 (PH1)
Arbor Biotechnologies23 enrolled7 locationsNCT06839235
Recruiting
Not Applicable
Oxalate Excretion Profile in Patients with a Heterozygous Mutation of the AGXT (alanine-glyoxylate Aminotransferase) Gene
Hyperoxaluria (Disorder)
Hospices Civils de Lyon25 enrolled1 locationNCT06283082